Conversion disorder in adults: Treatment

INTRODUCTION

Conversion disorder (functional neurologic symptom disorder) is characterized by neurologic symptoms (eg, weakness, abnormal movements, or nonepileptic seizures) that are inconsistent with a neurologic disease, but cause distress and/or impairment [1]. The disorder is common in clinical settings and often has a poor prognosis [2-5].  

This topic reviews treatment of conversion disorder. The terminology, diagnosis, epidemiology, prognosis, clinical features, and assessment are discussed separately, as are specific subtypes of conversion disorder (psychogenic nonepileptic seizures and psychogenic movement disorders):

(See "Conversion disorder in adults: Terminology, diagnosis, and differential diagnosis".)

(See "Conversion disorder in adults: Epidemiology, pathogenesis, and prognosis".)

(See "Conversion disorder in adults: Clinical features, assessment, and comorbidity".)

                     

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Jun 10, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.
  2. Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010; 112:747.
  3. Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011; 82:810.
  4. Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 2014; 85:220.
  5. Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat 2011; 2011:274736.
  6. Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012; 83:842.
  7. Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i13.
  8. Stonnington CM, Barry JJ, Fisher RS. Conversion disorder. Am J Psychiatry 2006; 163:1510.
  9. Aybek S, Hubschmid M, Mossinger C, et al. Early intervention for conversion disorder: Neurologists and psychiatrists working together. Acta Neuropsychiatrica 2013; 25:52.
  10. McCormack R, Moriarty J, Mellers JD, et al. Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry 2014; 85:895.
  11. Saifee TA, Kassavetis P, Pareés I, et al. Inpatient treatment of functional motor symptoms: a long-term follow-up study. J Neurol 2012; 259:1958.
  12. Shen W, Bowman ES, Markand ON. Presenting the diagnosis of pseudoseizure. Neurology 1990; 40:756.
  13. Stone J, Carson AJ, Sharpe M. Psychogenic movement disorders: Explaining the diagnosis. In: Psychogenic movement disorders and other conversion disorders, Hallett M, Lang AE, Jankovic J, et al. (Eds), Cambridge University Press, Cambridge 2011. p.254.
  14. Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011; 20:308.
  15. Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 2012; 79:282.
  16. Stone J. The bare essentials: Functional symptoms in neurology. Pract Neurol 2009; 9:179.
  17. Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010; 74:1986.
  18. Czarnecki K, Thompson JM, Seime R, et al. Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord 2012; 18:247.
  19. Jordbru AA, Smedstad LM, Klungsøyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med 2014; 46:181.
  20. Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 2011; 77:564.
  21. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69:881.
  22. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007; 69:889.
  23. Nielsen G, Stone J, Edwards MJ. Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. J Psychosom Res 2013; 75:93.
  24. Delargy MA, Peatfield RC, Burt AA. Successful rehabilitation in conversion paralysis. Br Med J (Clin Res Ed) 1986; 292:1730.
  25. Andrade C, Bhakta SG, Singh NM. Systematic enhancement of functioning as a therapeutic technique in conversion disorder. Indian J Psychiatry 2009; 51:134.
  26. Heruti RJ, Levy A, Adunski A, Ohry A. Conversion motor paralysis disorder: overview and rehabilitation model. Spinal Cord 2002; 40:327.
  27. Edwards MJ, Stone J, Nielsen G. Physiotherapists and patients with functional (psychogenic) motor symptoms: a survey of attitudes and interest. J Neurol Neurosurg Psychiatry 2012; 83:655.
  28. White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377:823.
  29. Oulis P, Kokras N, Papadimitriou GN, Masdrakis VG. Adjunctive low-dose amisulpride in motor conversion disorder. Clin Neuropharmacol 2009; 32:342.
  30. Messina A, Fogliani AM. Valproate in conversion disorder: a case report. Case Rep Med 2010; 2010:205702.
  31. LaFrance WC Jr, Keitner GI, Papandonatos GD, et al. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology 2010; 75:1166.
  32. Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry 2005; 66:1529.
  33. Rosebush PI, Mazurek MF. Treatment of conversion disorder in the 21st century: have we moved beyond the couch? Curr Treat Options Neurol 2011; 13:255.
  34. Maldonado JR. Conversion disorder. In: Gabbard's Treatments of Psychiatric Disorders, Fourth Edition, Gabbard GO. (Ed), American Psychiatric Publishing, Inc., Washington, DC 2007. p.595.
  35. Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn 2003; 51:29.
  36. Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom 2002; 71:66.
  37. Reuber M, Burness C, Howlett S, et al. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res 2007; 63:625.
  38. Mayor R, Howlett S, Grünewald R, Reuber M. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia 2010; 51:1169.
  39. Kompoliti K, Wilson B, Stebbins G, et al. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord 2014; 20:60.
  40. Stone J, Hoeritzauer I, Brown K, Carson A. Therapeutic sedation for functional (psychogenic) neurological symptoms. J Psychosom Res 2014; 76:165.
  41. Medlin F, Aybek S, Berney A, et al. Psychogenic tetraparesis and bilateral upper limb dystonia, regressive under short propofol-induced sedation and during hepatic encephalopathy. Psychosomatics 2012; 53:485.
  42. Yutzy SH, Parish BS. Somatoform disorders. In: The American Psychiatric Publishing Textbook of Psychiatry, Fifth Edition, Hales RE, Yudofsky SC, Gabbard GO. (Eds), American Psychiatric Publishing, Washington, DC 2008. p.609.
  43. Poole NA, Wuerz A, Agrawal N. Abreaction for conversion disorder: systematic review with meta-analysis. Br J Psychiatry 2010; 197:91.
  44. Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord 2010; 25:1501.
  45. Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry 2014; 85:191.
  46. Garcin B, Roze E, Mesrati F, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry 2013; 84:1043.
  47. Ataoglu A, Ozcetin A, Icmeli C, Ozbulut O. Paradoxical therapy in conversion reaction. J Korean Med Sci 2003; 18:581.
  48. Shapiro AP, Teasell RW. Behavioural interventions in the rehabilitation of acute v. chronic non-organic (conversion/factitious) motor disorders. Br J Psychiatry 2004; 185:140.
  49. Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i2.